Feb-17 -

Lymphoma Group

EORTC 20012 – BEACOPP (4 cycles escalated + 4 cycles baseline) versus ABVD (8 cycles) in stage III & IV Hodgkin’s Lymphoma.

Building off of the results of EORTC trials H9,10, and 12, in 2016, this EORTC trial compared two different chemotherapy regiments (ABVD 8 and BEACOPP 4 + 4) and found similar results in event-free and overall survival in patients with high-risk advanced-stage Hodgkin’s Lymphoma.


Go to Top